$HQ SEC Filings

Filed On	Filing
21 Oct 2026	Form 4: Fitzsimons Catherine Michele, CLO and CCO Granted 601,932 Stock Option (Right to Buy) ($6.49M)
16 Sep 2026	Form 4: Chew Qian Yi Amanda, Chief Product Officer Granted 17,857 Restricted Stock Unit
15 Sep 2026	Form 4: Fitzsimons Catherine Michele, CL and CO Granted 34,372 Restricted Stock Unit · Received 2,148 shares by exercise or conversion · Returned 1,122 shares to the issuer ($17.1K) · 1 more
15 Sep 2026	Form 4: Gould Greg, Chief Financial Officer Granted 54,995 Restricted Stock Unit · Received 3,437 shares by exercise or conversion · Returned 1,272 shares to the issuer ($19.4K) · 1 more
15 Sep 2026	Form 4: Tan Si-Hui, Chief Science Officer Granted 55,000 Stock Option (Right to Buy) · Granted 91,659 Restricted Stock Unit · Received 3,600 shares as a grant or award · 3 more
15 Sep 2026	Form 4: Fitzsimons Joseph Francis, Director Granted 229,148 Restricted Stock Unit · Received 14,321 shares by exercise or conversion · Returned 3,438 shares to the issuer ($52.3K) · 1 more
14 Aug 2026	SCHEDULE 13G/A
10 Aug 2026	Form 3: Chew Qian Yi Amanda, Chief Product Officer
04 Aug 2026	REPORT OF FOREIGN PRIVATE ISSUER
04 Aug 2026	REPORT OF FOREIGN PRIVATE ISSUER
03 Aug 2026	REPORT OF FOREIGN PRIVATE ISSUER
09 Jul 2026	SCHEDULE 13D
25 Jun 2026	SCHEDULE 13G
28 May 2026	REGISTRATION STATEMENT
11 May 2026	Form 3: Fitzsimons Catherine Michele, Chief Legal Officer No securities owned
05 May 2026	REPORT OF FOREIGN PRIVATE ISSUER
04 May 2026	REPORT OF FOREIGN PRIVATE ISSUER
24 Apr 2026	PROSPECTUS
23 Apr 2026	EFFECT
21 Apr 2026	CORRESP

Comments